Pharma companies are leveraging technology and mobile apps to develop patient-centric solutions to address specific, previously unmet, needs.
I had the pleasure of serving as host at the recent eyeforpharma Philadelphia Awards during the eyeforpharma 2015 conference. It was great to be part of a celebration of the innovative initiatives coming out of the pharmaceutical industry.
The Helio, a next-generation disease and lifestyle mobile application developed by Novartis & INVIVO Communications won “Most Valuable Patient Initiative”. The patient services app supports behavior, disease tracking and motivation throughout treatment. In addition, Lisa Banks from AstraZeneca took home the “Customer Innovator Award” for the mHealth app, Me&MyCOPD. The COPD management and lifestyle app was designed for patients 55+ to interface with their physicians. It is tremendous to see companies leveraging technology to address specific, previously unmet, needs of patients. Our recent study of the needs of 10,000 patients globally underscores the need for more patient centric programs and capabilities to compliment treatments and positively affect outcomes.
Boehringer Ingelheim won the “Most Impactful Emerging or Global Initiative” with its innovative “School for Intrapreneurs”. The school serves as an international internal incubator and accelerator program for the creation of disruptive ideas that often receive internal resistance.
Diego Miralles, M.D., Global Head of Innovation for Janssen was recognized with the evening’s “Lifetime Achievement Award” for his more than 13 years of dedication to innovation.
We spend so much time navigating through economic realities, changes in the market and products and digital and business model disruption that it is nice to stop and marvel at the impressive accomplishments happening around us. Accenture is proud to support an event that recognizes innovation and growth in our industry and we look forward to following these and other initiatives that drive better patient outcomes.